Phase III, Randomized, International, Multicenter, Open Label, With Blinded Adjudication of Outcomes, Non-Inferiority Clinical Trial to Explore the Safety and Efficacy of Ticagrelor Compared With Clopidogrel in Patients With Acute Coronary Syndrome With ST Elevation Treated With Pharmacological Thrombolysis.

Trial Profile

Phase III, Randomized, International, Multicenter, Open Label, With Blinded Adjudication of Outcomes, Non-Inferiority Clinical Trial to Explore the Safety and Efficacy of Ticagrelor Compared With Clopidogrel in Patients With Acute Coronary Syndrome With ST Elevation Treated With Pharmacological Thrombolysis.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 11 Mar 2018

At a glance

  • Drugs Ticagrelor (Primary) ; Clopidogrel
  • Indications Acute coronary syndromes
  • Focus Adverse reactions
  • Acronyms TREAT
  • Most Recent Events

    • 11 Mar 2018 The initial study results presented in an AstraZeneca media release.
    • 11 Mar 2018 According to an AstraZeneca media release, the initial study results were presented at the American College of Cardiologys 67th Annual Scientific Session.
    • 05 Mar 2018 According to an AstraZeneca media release, data from this trial will be presented at ACC 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top